Management of Influenza in Adults Older than 65 Years of Age: Cost-Effectiveness of Rapid Testing and Antiviral Therapy

@article{Rothberg2003ManagementOI,
  title={Management of Influenza in Adults Older than 65 Years of Age: Cost-Effectiveness of Rapid Testing and Antiviral Therapy},
  author={M. Rothberg and S. Bellantonio and D. Rose},
  journal={Annals of Internal Medicine},
  year={2003},
  volume={139},
  pages={321-329}
}
  • M. Rothberg, S. Bellantonio, D. Rose
  • Published 2003
  • Medicine
  • Annals of Internal Medicine
  • Context Drugs to treat influenza are cost-effective in adults younger than 65 years of age, but the cost-effectiveness of these drugs for people older than 65 years is unknown. Contribution For unvaccinated persons older than 65 years of age with influenza-like illness, empirical treatment with amantadine cost $1129 per quality-adjusted life-year (QALY), treatment with oseltamivir after rapid diagnostic testing cost $5025 per QALY, and empirical treatment with oseltamivir cost $10 296 per QALY… CONTINUE READING
    Antiviral Therapy for Influenza
    • 52
    Outcomes of adults hospitalised with severe influenza
    • 169
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 46 REFERENCES
    Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults.
    • 73
    • PDF
    Cost-effectiveness of newer treatment strategies for influenza.
    • 67
    Current strategies for management of influenza in the elderly population.
    • 49
    • PDF